The immune response to breast cancer, and the case for DC immunotherapy.

Allan, C P; Turtle, C J; Mainwaring, P N; Pyke, C; Hart, D N J

Allan, C P; Turtle, C J; Mainwaring, P N; Pyke, C; Hart, D N J.

Affiliation

Allan CP; Dendritic Cell Laboratory, Mater Medical Research Institute, Queensland, South Brisbane, Australia.

Cytotherapy ; 6(2): 154-63, 2004.

Article in En | MEDLINE | ID: mdl-15203992

Subject(s)

Breast Neoplasms/immunology; Breast Neoplasms/therapy; Cancer Vaccines/therapeutic use; Dendritic Cells/immunology; Dendritic Cells/transplantation; Immunotherapy, Adoptive; Adenoviridae/genetics; Adenoviridae/immunology; Animals; Antigens, Neoplasm/immunology; Cancer Vaccines/immunology; DNA, Neoplasm/genetics; DNA, Neoplasm/immunology; Female; Humans; Immunologic Memory; Mice; Peptides/immunology; Proteins/immunology; RNA, Neoplasm/genetics; RNA, Neoplasm/immunology; T-Lymphocytes/immunology

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Dendritic Cells / Breast Neoplasms / Immunotherapy, Adoptive / Cancer Vaccines Type of study: Prognostic_studies Limits: Animals / Female / Humans Language: En Journal: Cytotherapy Year: 2004 Document type: Article

Search on Google

XML

PubMed Links